{"id":2864,"date":"2020-03-25T09:15:00","date_gmt":"2020-03-25T09:15:00","guid":{"rendered":"https:\/\/www.xvivogroup.com\/us\/mfn_news\/valberedningen-foreslar-oforandrade-styrelsearvoden\/"},"modified":"2020-03-25T09:15:00","modified_gmt":"2020-03-25T09:15:00","slug":"valberedningen-foreslar-oforandrade-styrelsearvoden","status":"publish","type":"mfn_news","link":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/valberedningen-foreslar-oforandrade-styrelsearvoden\/","title":{"rendered":"Valberedningen f\u00f6resl\u00e5r of\u00f6r\u00e4ndrade styrelsearvoden"},"content":{"rendered":"<p><span><span><span>Till f\u00f6ljd av situationen med coronapandemin har XVIVO Perfusions valberedning beslutat att dra tillbaka f\u00f6rslaget om att XVIVO Perfusions \u00e5rsst\u00e4mma den 31 mars 2020 godk\u00e4nner en h\u00f6jning av styrelsearvodena (punkt 12 p\u00e5 dagordningen). I st\u00e4llet f\u00f6resl\u00e5r valberedningen of\u00f6r\u00e4ndrade styrelsearvoden j\u00e4mf\u00f6rt med 2019. Valberedningens \u00f6vriga f\u00f6rslag till \u00e5rsst\u00e4mman f\u00f6rblir of\u00f6r\u00e4ndrade.<\/span><\/span><\/span><\/p>\n<div class=\"mfn-footer\">\n<p><span><span>F\u00f6r ytterligare information, v\u00e4nligen kontakta: <\/span><\/span><\/p>\n<p><span><span>Christoffer Rosenblad, CFO, +46 735 192159, christoffer.rosenblad@xvivoperfusion.com<br \/>\nMagnus Nilsson, VD, +46 31-788 21 50, magnus.nilsson@xvivoperfusion.com<\/span><\/span><\/p>\n<p><span><span>F\u00f6r ytterligare information om XVIVO Perfusions verksamhet h\u00e4nvisas till bolagets hemsida, www.xvivoperfusion.com<\/span><\/span><\/p>\n<p><span><span>Denna information \u00e4r s\u00e5dan information som Xvivo Perfusion AB (publ) \u00e4r skyldigt att offentligg\u00f6ra enligt EU:s marknadsmissbruksf\u00f6rordning. Informationen l\u00e4mnades, genom ovanst\u00e5ende kontaktpersons f\u00f6rsorg, f\u00f6r offentligg\u00f6rande klockan 10:15 den 25 mars 2020.<\/span><\/span><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Till f\u00f6ljd av situationen med coronapandemin har XVIVO Perfusions valberedning beslutat att dra tillbaka f\u00f6rslaget om att XVIVO Perfusions \u00e5rsst\u00e4mma&#8230;<\/p>\n","protected":false},"template":"","class_list":["post-2864","mfn_news","type-mfn_news","status-publish","hentry","mfn-news-tag-mfn-ci","mfn-news-tag-mfn-ci-other","mfn-news-tag-mfn","mfn-news-tag-mfn-type-ir","mfn-news-tag-mfn-lang-sv","mfn-news-tag-mfn-regulatory","mfn-news-tag-mfn-regulatory-mar"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Valberedningen f\u00f6resl\u00e5r of\u00f6r\u00e4ndrade styrelsearvoden - XVIVO<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.xvivogroup.com\/us\/pressreleases\/valberedningen-foreslar-oforandrade-styrelsearvoden\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Valberedningen f\u00f6resl\u00e5r of\u00f6r\u00e4ndrade styrelsearvoden - XVIVO\" \/>\n<meta property=\"og:description\" content=\"Till f\u00f6ljd av situationen med coronapandemin har XVIVO Perfusions valberedning beslutat att dra tillbaka f\u00f6rslaget om att XVIVO Perfusions \u00e5rsst\u00e4mma...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.xvivogroup.com\/us\/pressreleases\/valberedningen-foreslar-oforandrade-styrelsearvoden\/\" \/>\n<meta property=\"og:site_name\" content=\"United States\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/valberedningen-foreslar-oforandrade-styrelsearvoden\\\/\",\"url\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/valberedningen-foreslar-oforandrade-styrelsearvoden\\\/\",\"name\":\"Valberedningen f\u00f6resl\u00e5r of\u00f6r\u00e4ndrade styrelsearvoden - XVIVO\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/#website\"},\"datePublished\":\"2020-03-25T09:15:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/valberedningen-foreslar-oforandrade-styrelsearvoden\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/valberedningen-foreslar-oforandrade-styrelsearvoden\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/valberedningen-foreslar-oforandrade-styrelsearvoden\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Valberedningen f\u00f6resl\u00e5r of\u00f6r\u00e4ndrade styrelsearvoden\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/#website\",\"url\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/\",\"name\":\"United States\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Valberedningen f\u00f6resl\u00e5r of\u00f6r\u00e4ndrade styrelsearvoden - XVIVO","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/valberedningen-foreslar-oforandrade-styrelsearvoden\/","og_locale":"en_US","og_type":"article","og_title":"Valberedningen f\u00f6resl\u00e5r of\u00f6r\u00e4ndrade styrelsearvoden - XVIVO","og_description":"Till f\u00f6ljd av situationen med coronapandemin har XVIVO Perfusions valberedning beslutat att dra tillbaka f\u00f6rslaget om att XVIVO Perfusions \u00e5rsst\u00e4mma...","og_url":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/valberedningen-foreslar-oforandrade-styrelsearvoden\/","og_site_name":"United States","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/valberedningen-foreslar-oforandrade-styrelsearvoden\/","url":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/valberedningen-foreslar-oforandrade-styrelsearvoden\/","name":"Valberedningen f\u00f6resl\u00e5r of\u00f6r\u00e4ndrade styrelsearvoden - XVIVO","isPartOf":{"@id":"https:\/\/www.xvivogroup.com\/us\/#website"},"datePublished":"2020-03-25T09:15:00+00:00","breadcrumb":{"@id":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/valberedningen-foreslar-oforandrade-styrelsearvoden\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.xvivogroup.com\/us\/pressreleases\/valberedningen-foreslar-oforandrade-styrelsearvoden\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/valberedningen-foreslar-oforandrade-styrelsearvoden\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.xvivogroup.com\/us\/"},{"@type":"ListItem","position":2,"name":"Valberedningen f\u00f6resl\u00e5r of\u00f6r\u00e4ndrade styrelsearvoden"}]},{"@type":"WebSite","@id":"https:\/\/www.xvivogroup.com\/us\/#website","url":"https:\/\/www.xvivogroup.com\/us\/","name":"United States","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.xvivogroup.com\/us\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/www.xvivogroup.com\/us\/wp-json\/wp\/v2\/mfn_news\/2864","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.xvivogroup.com\/us\/wp-json\/wp\/v2\/mfn_news"}],"about":[{"href":"https:\/\/www.xvivogroup.com\/us\/wp-json\/wp\/v2\/types\/mfn_news"}],"wp:attachment":[{"href":"https:\/\/www.xvivogroup.com\/us\/wp-json\/wp\/v2\/media?parent=2864"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}